Summary Human papillomavirus (HPV) infection appears to be an early event in cervical carcinogenesis with additional abnormalities being required for biological transformation. We have analysed 179 low-grade cervical squamous intra-epithelial lesions (SILs) and 15 normal cervices for the presence of HPV using both in situ hybridization and polymerase chain reaction (PCR). PCR was performed with GP5+/GP6+ primers followed by hybridization using probes for low (HPV 6, 11, 40, 42, 43, 44), intermediate (HPV 31, 33, 35, 39, 51, 52, 58, 59, 66 and 68) and high-risk HPVs (HPV 16, 18, 45 and 56). Interphase cytogenetic analysis using pericentromeric probes for chromosomes 1, 3, 4, 6, 10, 11, 17, 18 and X was also performed to identify numerical chromosomal abnormalities. Tetrasomy of all nine chromosomes was identified within basal keratinocytes, was restricted to epithelia infected with high risk (17 of 46) or intermediate risk (23 of 83) HPVs but was not HPV type-specific. Tetrasomy was not identified in any of the epithelia infected with low risk HPVs (n = 62). These numbers include multiple infection. These findings indicate that the induction of tetrasomy is a property restricted to high and intermediate-risk HPV types but that it is not type-specific. The factors governing which lesions will develop this abnormality are as yet unclear.
Human papillomaviruses (HPV) are members of a group of small, double-stranded DNA viruses which are causally associated with anogenital carcinomas and particularly with cervical carcinoma (Arends et al, 1990) . The mechanisms by which the HPVs function in malignant progression appear predominantly to involve the activity of the two viral oncoproteins, E6 and E7. However, the development of invasive carcinoma is a multistep process involving the accumulation of a number of mutational events. Alterations to oncogenes and/or tumour suppressor genes, as well as parameters such as smoking and other viral infections appear to be required in parallel to infection (Herrington, 1995) . In vitro studies have shown that HPV can induce genetic abnormalities including chromosomal imbalances in stably transfected cells (Hashida and Yasumoto, 1991; White et al, 1994; Steenbergen et al, 1996; Salinas-Toldo et al, 1997) . However, stable transfection is associated with viral integration. Consequently, early genetic events related to productive infection cannot be studied by this approach. Moreover, although chromosome abnormalities have long been known to occur in invasive cervical carcinoma (Atkin, 1997), it has not been established at which stage of in vivo transformation these changes occur.
A preliminary study from our group showed that numerical chromosomal abnormalities occur in some HPV-infected lowgrade cervical squamous intra-epithelial lesions (SILs) (Southern et al, 1997) . In this study, we have extended this to a large series of low-grade SILs and have analysed a broader range of chromosomes by including chromosomes 4, 6 and 10 which have been reported to be abnormal in in vitro studies of HPV-induced immortalization (Steenbergen et al, 1996; Salinas-Toldo et al, 1997) . Interphase cytogenetics showed tetrasomy with all of the chromosomes in 17/46 lesions infected with high-risk HPVs and 23/83 lesions infected with intermediate-risk HPVs: this difference was not statistically significant (χ 2 = 1.18, df = 1, P > 0.05). In all lesions, tetrasomy was present throughout the thickness of the epithelium, including the basal layer. None of the lesions infected with low-risk types or the 15 normal cervices showed any numerical chromosomal abnormality. Basal keratinocyte tetrasomy was therefore restricted to infection with high-and intermediate-risk HPVs. Although infection with a wide range of HPV types was identified, the presence of tetrasomy was not type-specific.
MATERIALS AND METHODS

Tissue specimens
One hundred and seventy-nine low-grade squamous intra-epithelial lesions (SILs) and 15 normal cervices were identified from the diagnostic files of the Royal Liverpool University Hospital. The low-grade lesions comprised condylomata acuminata (n = 27), flat condylomata (n = 53) and cervical intra-epithelial neoplasia (CIN) grade 1 (n = 99). All of the diagnoses were confirmed by CSH.
DNA extraction
Three 5-µm formalin-fixed, paraffin sections of cervical biopsy material were dewaxed in xylene (2 × 5 min) followed by 96%
Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific ethanol (2 × 5 min), then pelleted, air-dried and incubated overnight at 42°C with 200 µg ml -1 proteinase K (Boehringer Mannheim) in 200 mM Tris-HCI pH 8.0, 1 mM EDTA. The digest was heated to 95°C for 20 min to stop enzymatic activity, centrifuged and the supernatant used for polymerase chain reaction (PCR). The quality of the DNA was assessed by amplifying a 209 bp β-globin fragment using PCO3 and PCO5 primers (Jacobs et al, 1995) .
HPV typing by PCR
Ten to 15 µl of the extracted DNA was used in a 50 µl PCR reaction containing 50 mM potassium chloride, 10 mM Tris-HCI (pH 8.3), 200 µM of each dNTP, 3.5 mM magnesium chloride, 1 U of Taq DNA polymerase and 50 pmol each of the consensus GP5+/GP6+ primers. The primers amplify a fragment of 140-150 bp (depending on HPV type) from the L1 gene. PCR conditions comprised an initial denaturation step at 95°C for 4 min followed by 40 cycles of: denaturation at 94°C for 1 min, annealing at 40°C for 2 min, extension at 72°C for 1.5 min, followed by a final extension step at 72°C for 7 min to ensure complete extension of the amplified DNA. Ten microlitres of the PCR product were analysed on a 1.7% agarose gel stained with ethidium bromide. The gel was then denatured and blotted on to positively charged nylon (Southern blot). The remaining PCR product was diluted 1:10 and denatured for 10 min at 95°C. One microlitre of denatured DNA was then applied on to individual nylon memranes and placed under UV light for 3 min, followed by baking at 80°C for 1 h.
Membranes were placed into pre-hybridization buffer (0.02% sodium dodecyl sulphate (SDS), 1% blocking reagent (Boehringer Mannheim) in 2 × standerd saline citrate (SSC) for 1 h at 55°C and hybridized overnight at the same temperature using individual 5′ digoxigenin-labelled oligonucleotide probes specific for low-risk (HPV 6, 11, 40, 42, 43 and 44), 33, 35, 39, 51, 52, 58, 59, 66 and 68) and high-risk (HPV 16, 18, 45 , and 56) HPV types (Jacobs et al, 1995) . Hybridization was followed by washes in post-hybridization buffer (0.1% SDS in 2 × SSC) 3 × 10 min at 55°C and in blocking solution (0.5% Tween-20, 1% blocking reagent in 0.1 M Tris-HCl, pH 7.5) for 45 min at room temperature. Signal was detected with anti-digoxigenin-alkaline phosphatase conjugate diluted 1:5000 in blocking solution for 30 min and developed using nitroblue tetrazolium/bromochloroindolyl phosphate (NBT/BCIP).
HPV localization by in situ hybridization
Tissue sections were dewaxed in xylene, rehydrated through graded alcohols and washed in Molecular Biology Grade (MBG) water. Sections were digested with 0.5 mg ml -1 proteinase K in 0.1 M Tris-HCl pH 7.6 for 20 min at 37°C and hybridized with a mixture of nick-translated digoxigenin labelled probes derived from HPV 6, 11, 16, 18, 31, 33 plasmid clones in 50% formamide, 20 × SSC, 10% dextran sulphate, under low stringency conditions to allow hybridization to a wide range of HPV types (Southern et al, 1997) . When multiple infection was identified by PCR in lesions showing chromosome abnormalities, in situ hybridization with the appropriate individual probes was carried out to establish the morphological localization of the individual HPV types (i.e. HPV 6, 11, 16, 18, 31, 35, 45, 51, 56 and 66; see Results) . All of the probes used for in situ hybridization consisted of the cloned whole viral genome (see Southern et al (1997) for details of the source of each clone).
Interphase cytogenetic analysis
Tissue sections were dewaxed in xylene, rehydrated through graded alcohols, washed in MBG water and immersed in 1 M sodium thiocyanate at 80°C for 10 min. Sections were digested with 4 mg ml -1 of pepsin (Sigma) in 0.2 M hydrochloric acid for 20 min at 37°C, followed by washes with water and air-drying. Chromosome probes (1, 3, 4, 6, 10, 11, 17 , 18 X) (Oncor) at a concentration of 1 ng µl -1 in 60% formamide, 2 × SSC, 10% dextran sulphate and 1 µg µl -1 sheared salmon sperm DNA were applied to the dry sections. The probe and tissue were denatured at 80°C for 8 min and hybridized overnight in a 37°C oven, as previously described (Southern and Herrington, 1996) . These probes allow the assessment of centromere number per cell nucleus but do not provide information about non-centromeric chromosomal areas. The number of signals per nucleus was counted in a total of 200 nuclei from each lesion following the rules previously established for signal counting. The presence of three and four signals per nucleus in > 10% of nuclei determines trisomic and tetrasomic cell populations respectively as previously validated (Southern and Herrington, 1996, 1997) .
RESULTS
HPV typing and localization of infection
HPV typing by PCR All of the tissues examined were positive for β-globin by PCR indicating the presence of adequate DNA for further analysis. One hundred and seventy-three of 179 specimens were found to be HPV-positive. Sixty-two lesions contained low-risk HPVs (HPV 6 (n = 30), 11 (n = 19), 40 (n = 1), 42 (n = 5), 43 (n = 6), 44 (n = 1)), 46 lesions contained high-risk HPVs (HPV 16 (n = 21), 18 (n = 13), 45 (n = 4), 56 (n = 8)) and 83 lesions contained intermediaterisk HPVs (HPV 30 (n = 1), 31 (n = 7), 33 (n = 3), 35 (n = 16), 39 (n = 3), 51 (n = 12), 52 (n = 3), 58 (n = 14), 59 (n = 3), 66 (n = 19), 68 (n = 2)). HPV 30 and an unknown type with homology to HPV43 (77%), thus classified as low risk, were identified by DNA sequencing. Multiple types were identified in 17 cases (6/11, 6/16, 6/18, 6/31, 6/35 (n = 2), 6/66, 11/18, 11/66, 16/56, 18/31, 18/56, 35/51, 35/66, 45/51, 51/66, and 59/51/42) and were included individually in the above HPV numbers. The 15 normal cervices were HPV-negative.
In situ hybridization
Six of the 173 specimens that were HPV-positive by PCR were negative by in situ hybridization. All the other specimens were positive with both methods allowing morphological localization of the infection to be established (Figure 1) . The six non-infected cases and the 15 normal cervices were negative with both methods. In situ hybridization also allowed the localization of individual HPV types to different morphological areas in the nine biopsies in which both multiple HPV types and chromosome abnormalities were identified: this allowed accurate karyotypic assessment of these areas. 
Chromosome analysis
Correlation of tetrasomy with HPV types
Tetrasomy was present with all nine chromosomal probes in a total of 40 lesions (Figure 2 ). In 36 lesions, tetrasomy persisted throughout the whole epithelial thickness, extending from basal to superficial epithelial cells. In four cases, initial sections showed apparently focal tetrasomy in suprabasal cells. Further sections were analysed from these lesions and tetrasomy of basal cells was identified indicating that the apparent suprabasal localisation of tetrasomy in the initial sections was due to cross-cutting artefact in small lesions. All the other lesions, including the normal control tissues were disomic, showing three signals in 0.5-2.5% of nuclei and four signals in 0.5%. Overall, of the 46 lesions infected with high-risk HPVs, 17 showed basal cell tetrasomy and, of the 83 lesions infected with intermediate-risk HPVs, 23 showed basal cell tetrasomy ( Figure  2) . The difference between these two groups is not statistically significant (χ 2 = 1.18, df = 1, P > 0.05). All of the 62 lesions infected with low-risk HPVs were disomic. These figures include the multiple infections. Nine lesions showing basal cell tetrasomy were infected with more than one HPV type. In order to identify which HPV type was present in the area showing chromosome abnormality, in situ hybridization was performed using digoxigenin-labelled probes specific for each type. The results are summarized in Table 1 .
Correlation of the interphase cytogenetic and HPV in situ hybridization data demonstrated that, although the chromosome abnormalities were confined to HPV-infected areas, they were not present throughout the HPV-infected area.
DISCUSSION
In this study, we have demonstrated, in a series of 179 low-grade SILs of the cervix, that basal keratinocyte tetrasomy is associated with infection with high-and intermediate-but not low-risk HPV types. This is consistent with the fact that the E6 and E7 proteins of high-risk HPVs interact with components of the cell cycle control machinery, including p53, pRb and p21 (Slebos et al, 1994; Galloway and McDougall, 1996; Xiong et al, 1996) . Endoreduplication has been described in association with the abrogation of p21 function as a result of E7 binding (Stewart et al, 1999) . Similarly, duplication of cellular DNA content as identified by flow cytometry has been induced by E6, E7 and E2 protein expression, particularly in the presence of mitotic spindle inhibitors (di Leonardo et al, 1997; Frattini et al, 1997) . These in vitro findings are consistent with the observation that mitotic checkpoint abnormalities can be induced by both E6 and E7 proteins (Steinmann et al, 1994; Thomas and Laimans, 1998) . In addition, it has been shown that the absence or loss of function of wild-type p53 from mouse embryonic fibroblasts results in multiple copies of functionally competent centrosomes (Fukasawa et al, 1996) . However, our finding of tetrasomy indicates not only chromosome re-duplication, consistent with endo-reduplication, but also centromere separation, implying that the mechanism by which cellular DNA is reduplicated involves separation of sister chromatids.
Although tetrasomy was only found in lesions infected with high-and intermediate-risk HPVs, it was not type-specific and there was no significant difference in the frequency of tetrasomy in lesions infected with intermediate-risk, by comparison with high-risk types. Whilst this observation casts some doubt over the distinction between high-and intermediate-risk HPVs, these two groups were defined on the basis of clinical risk association (Lorincz et al, 1992) . These clinical associations are likely to be dependent upon a wide range of biological properties of the individual viral types and hence retention of the distinction between high-and intermediate-risk HPVs may be useful in identifying factors which are important in neoplastic transformation by these viruses. A wide range of HPV types was identified in the lesions analysed and tetrasomy was present in lesions infected with HPVs 16, 18, 31, 33, 35, 39, 51, 52, 56, 58 and 66 . However, these viral types were also present in lesions showing no numerical chromosomal abnormality. In addition, HPV in situ hybridization demonstrated that basal cell tetrasomy was not present throughout the HPV-infected areas in any of the lesions showing tetrasomy. These two observations indicate that other factors are involved in determining whether basal cell tetrasomy will develop. Possible viral factors include: the level of viral early gene expression and its relationship to keratinocyte differentiation; the presence of different HPV-type variants; and persistence of viral infection, which has been shown to be an important factor in determining progression of intra-epithelial lesions (Remminck et al, 1995) . Furthermore, cellular factors such as activation of oncogenes, inactivation of tumour suppressor genes, abnormalities of cell cycle regulators, smoking, immunosuppression and the presence of other infectious agents may also be involved (Herrington, 1995; Howley, 1996) .
The morphological location of the numerical chromosomal abnormalities identified in this study suggests that the induction of tetrasomy is more likely to be related to initial viral early gene expression than to viral DNA replication. Tetrasomy was present in the basal and suprabasal cell layer and, in the majority of lesions, extends throughout the epithelium indicating persistence despite squamous cell differentiation. In four lesions, tetrasomy was present only in basal and suprabasal keratinocytes and did not extend to the superficial layers. This observation suggests that tetrasomy begins in the proliferating part of the epithelium and implies that this phenomenon is not directly related to viral DNA replication which occurs in the intermediate and superficial layers of the epithelium (Howley, 1996) . Moreover, as it is known that the E6 and E7 genes are expressed in basal epithelial cells (Higgins et al, 1992; Nilsson et al, 1996) , it is consistent with in vitro evidence that the E6 and E7 proteins can induce DNA rereplication and, after more prolonged exposure, chromosome abnormalities in transfected cells (Xiong et al, 1996) .
In conclusion, basal cell tetrasomy occurs in approximately 31% of low-grade cervical SILs infected with high-and intermediate-risk HPVs but not in those infected with low-risk HPVs. Tetrasomy is not type-specific and is not always present throughout the HPV-infected epithelium. Further investigation of this phenomenon will provide important information regarding the mechanisms by which HPVs interfere with cell cycle control.
